MBBS | MD General Medicine | Specialist Accreditation in Medical Oncology- European Society of Oncology (ESMO) Certification | DM (Medical Oncology) Cancer Institute, Adyar, Chennai
All slots are booked for the doctor today. Please check for another day or call us at 011 - 49674967.
Next Available Slot
Request Call Back
Doctor Consultation Charges (Video Consultation) - Rs. Price not Available/-
Confirm Appointment
Are you new to hospital?
Go Back
Your appointment is confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Your Appointment will be confirmed after generating Pre Registration ID and making payment for consultation now.
Patient Registration Details
1
Basic Details
Other Details
Declaration
Go Back
Patient Registration Details
Basic Details
2
Other Details
Declaration
Go Back
Patient Registration Details
Basic Details
Other Details
3
Declaration
Consent and Declaration
I, the undersigned, declare that the above information provided by me are true to the best of my knowledge and hereby provide my consent to the Manipal Hospital to provide Medical Care, Treatment, Conduct Investigations and Diagnostic Procedures necessary for the above mentioned individual by Medical Staff at Manipal Hospital. I, also understand that Manipal Hospital will not be responsible for any loss, damage or theft of any Personal Property/Belongings of Me/Patient/Visitors within the Hospital Premises. Including Patients rooms and Parking area. I agree to follow all the rules and regulations of Hospital and clear all the expenses incurred for My/Patient treatment on time as per the Terms and Conditions of Manipal Hospital,
I would like to receive Self/Patient reports by Email
I would like to receive Hospital Info Alerts reports by Email
If consent provided on behalf of the patient.
I hereby give my consent and authorize Manipal Hospitals to process, store,use,disclose my personal or sensitive information/data collected as per Manipal Privacy Policy
Go Back
We have sent you an OTP on
+91 8745360000
Resend OTP
Did not receive OTP? You can request for another OTP click resend option
Go Back
Patient Details
Confirm Appointment
Are you new to hospital?
Go Back
Go Back
Your Appointment will be confirmed after generating Pre Registration ID and making payment for consultation now.
Patient Registration Details
1
Basic Details
Other Details
Declaration
Go Back
Patient Registration Details
Basic Details
2
Other Details
Declaration
Go Back
Patient Registration Details
Basic Details
Other Details
3
Declaration
Consent and Declaration
I, the undersigned, declare that the above information provided by me are true to the best of my knowledge and hereby provide my consent to the Manipal Hospital to provide Medical Care, Treatment, Conduct Investigations and Diagnostic Procedures necessary for the above mentioned individual by Medical Staff at Manipal Hospital. I, also understand that Manipal Hospital will not be responsible for any loss, damage or theft of any Personal Property/Belongings of Me/Patient/Visitors within the Hospital Premises. Including Patients rooms and Parking area. I agree to follow all the rules and regulations of Hospital and clear all the expenses incurred for My/Patient treatment on time as per the Terms and Conditions of Manipal Hospital,
I would like to receive Self/Patient reports by Email
I would like to receive Hospital Info Alerts reports by Email
If consent provided on behalf of the patient.
I hereby give my consent and authorize Manipal Hospitals to process, store,use,disclose my personal or sensitive information/data collected as per Manipal Privacy Policy
Go Back
We have sent you an OTP on
Resend OTP
Did not receive an OTP? You Can Request For Another OTP Click Resend Option
Go Back
Patient Details
×
ALREADY APPOINTMENT IS AVAILABLE FOR THIS PATIENT
×
We see that your email address is not updated in our system. Hence, we couldn't able to complete this transaction.We request you to call our appointment helpline number: 1800 102 5555 to book an appointment.
The Mobile Number entered is not registered with Manipal Hospitals.
To continue, re-enter your Registered Mobile Number or Generate Pre Registration ID and make payment for the Doctor Appointment.
The entered UHID Number is not registered with Manipal Hospitals.
To continue, re-enter your Register or Generate Pre Registration ID and make payment for the Doctor Appointment.
₹ 1100-900-
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
Go back to change your appointment slot
We have sent you an OTP on
+91 8745360000
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
Gynaecological Malignancies - Carcinoma Ovary, the endometrium
Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
Soft-tissue Sarcomas and Osteosarcoma
Thoracic Malignancies - Lung Carcinoma
Immunotherapy
Precision Oncology
Languages Spoken
English
Hindi
Tamil
Awards & Achievements
First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.
Talks & Publications
Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
Co-Organizer of Best Of SABCS 2018 April 2018.
Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 percent cancers are due to poor lifestyle" to Financial Express. Click Here
Languages Spoken
English
Hindi
Tamil
Fellowship & Membership
European Society of Medical Oncology (ESMO)
ASCO
NCR oncology group
ISMPO
ICON
Dwarka IMA
SIOP
Field of Expertise
Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
Gynaecological Malignancies - Carcinoma Ovary, the endometrium
Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
Soft-tissue Sarcomas and Osteosarcoma
Thoracic Malignancies - Lung Carcinoma
Immunotherapy
Precision Oncology
Awards & Achievements
First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.
Talks & Publications
Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
Co-Organizer of Best Of SABCS 2018 April 2018.
Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 percent cancers are due to poor lifestyle" to Financial Express. Click Here
Field of Expertise
Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
Gynaecological Malignancies - Carcinoma Ovary, the endometrium
Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
Soft-tissue Sarcomas and Osteosarcoma
Thoracic Malignancies - Lung Carcinoma
Immunotherapy
Precision Oncology
Fellowship & Membership
European Society of Medical Oncology (ESMO)
ASCO
NCR oncology group
ISMPO
ICON
Dwarka IMA
SIOP
Languages Spoken
English
Hindi
Tamil
Awards & Achievements
First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.
Talks & Publications
Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
Co-Organizer of Best Of SABCS 2018 April 2018.
Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 percent cancers are due to poor lifestyle" to Financial Express. Click Here
Awards & Achievements
First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.
Fellowship & Membership
European Society of Medical Oncology (ESMO)
ASCO
NCR oncology group
ISMPO
ICON
Dwarka IMA
SIOP
Field of Expertise
Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
Gynaecological Malignancies - Carcinoma Ovary, the endometrium
Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
Soft-tissue Sarcomas and Osteosarcoma
Thoracic Malignancies - Lung Carcinoma
Immunotherapy
Precision Oncology
Languages Spoken
English
Hindi
Tamil
Talks & Publications
Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
Co-Organizer of Best Of SABCS 2018 April 2018.
Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 percent cancers are due to poor lifestyle" to Financial Express. Click Here
Talks & Publications
Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck malignancy http://medej.tnmgrmu.ac.in 2 (2).
Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al.
Novel formulations of docetaxel, paclitaxel, and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al.
Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce a Durable Response Peush Bajpai et al. Journal of Gastrointestinal Cancer volume 50, pages943–946 (2019).
Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al.
Submitted for Publication: Collusion: The façade and its implications on Total pain management in palliative care -IJPC_81_20 (Indian Journal of palliative care Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai.
Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141 patients, ICON 2009 Chennai.
Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid Leukemia – Chronic Phase treated with Imatinib mesylate AND possible correlation with electrolyte imbalances. Asia-Pacific Hematology consortium held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21.
A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane.
A multi-center, observational, data collection registry study to monitor the routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY INTAS PHARMACEUTICALS LTD) in Indian patients.
A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma.
Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient).
Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018.
Co-Organizer of Best Of SABCS 2018 April 2018.
Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice (GCP) on 1st March 2019.
CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019.
Dr. Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA. Click Here
Dr. Peush Bajpai explains about how early diagnosis and detection can identify Breast Cancer symptoms and treat it successfully on TV9 Bharatvarsh (Digital) | FB Live Session. Click Here
Dr. Peush Bajpai in an authored article on Watch out, lumps are not the only symptom of breast cancer observing Breast Cancer Awareness Month in Times Now News. Click Here
Dr. Peush Bajpai in an exclusive story on Oncologist answers FAQs on the ideal routine for cancer treatment in Times Now| World Cancer Day. Click Here
Dr. Peush Bajpai on Cancer and Precision Medicine in a live webinar on Business World.Click Here
Dr. Peush Bajpai on Cancer Treatment: Can I Have Chemotherapy During Pregnancy? in The Healthsite (Zee Digital) | Exclusive story.Click Here
Dr. Peush Bajpai on Doctor Explains: Menace of cancer in India| The Financial Express | World Cancer Day. Click Here
Dr. Peush Bajpai said in an exclusive Story, "Nearly 50-60 percent cancers are due to poor lifestyle" to Financial Express. Click Here
Fellowship & Membership
European Society of Medical Oncology (ESMO)
ASCO
NCR oncology group
ISMPO
ICON
Dwarka IMA
SIOP
Field of Expertise
Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma
Gynaecological Malignancies - Carcinoma Ovary, the endometrium
Haematological Malignancies - Multiple Myeloma, CML, CLL, and Autologous Bone marrow transplant
Soft-tissue Sarcomas and Osteosarcoma
Thoracic Malignancies - Lung Carcinoma
Immunotherapy
Precision Oncology
Languages Spoken
English
Hindi
Tamil
Awards & Achievements
First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass.
First prize in the All India Quiz at the Lymphoma leukemia meet in Mumbai organized by the European Society of Medical Oncology.
Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances.
The management of breast cancer depends on several factors such as the size and location of the tumour and also if the tumour has spread to other parts of the body. Surgery with or without radiation therapy is recommended in patients with early disease. Chemotherapy and hormonal therapy are usually reserved in metastatic disease.
Drug treatment for cancer is known as chemotherapy. Chemotherapy is used alone or in combination with radiation or surgery to manage different types of cancer.
Yes. All chemotherapy has side-effects depending on the drugs given. Some common side-effects include bleeding, constipation, diarrhoea, fatigue, fever, hair loss, loss of appetite, mouth sores, nausea, pain, etc.
Osteosarcoma is a type of bone cancer usually found at the end of long bones, mostly around the knee.
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.